Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TOI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOncology Institute files routine investor presentation disclosure
Filed March 13, 2026 · Period ending March 13, 2026 · ~1 min read
Key Changes
-
low
Company furnished investor presentation dated March 13, 2026 for use in meetings with investors under Regulation FD requirements. No material business developments or financial information disclosed in the filing itself.
Item 7.01 verify on EDGAR →
Summary
The Oncology Institute filed a routine 8-K to disclose an investor presentation it prepared for meetings with investors. This is a standard Regulation FD compliance filing to ensure equal access to information shared with select investors. The filing contains no material business updates, financial results, or strategic announcements—it simply attaches the presentation deck as an exhibit.
For retail investors, this filing has minimal immediate impact. The presentation itself may contain useful information about the company's strategy and operations, but the 8-K filing is purely procedural. Watch for any subsequent filings or press releases that might contain substantive business updates or financial guidance that could materially affect the stock.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The Oncology Institute, Inc. (the “Company”) has prepared an investor presentation (the “Investor Presentation”) to use in meetings with investors. A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The company has prepared and furnished an investor presentation for use in meetings with investors. This is a routine disclosure under Regulation FD to ensure equal access to information. The presentation itself is attached as an exhibit but no specific content or material business developments are disclosed in the 8-K body.
Event · Item 9.01 — Financial Statements and Exhibits
The Oncology Institute filed an 8-K to disclose an investor presentation dated March 13, 2026.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Investor Presentation, dated March 13, 2026.
The company filed an investor presentation dated March 13, 2026 as Exhibit 99.1. This is a routine disclosure of materials used for investor communications, with no specific business event or financial information disclosed in the 8-K body itself.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify